@article{5d72a24694324123ac1e90978917502c,
title = "Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab",
abstract = "N/A",
keywords = "Angiogenesis Inhibitors, Fluorescein Angiography, Follow-Up Studies, Fundus Oculi, Humans, Infant, Intravitreal Injections, Male, Newborn, Ranibizumab, Recurrence, Retina, Retinopathy of Prematurity, Time Factors, Vascular Endothelial Growth Factor A, Angiogenesis Inhibitors, Fluorescein Angiography, Follow-Up Studies, Fundus Oculi, Humans, Infant, Intravitreal Injections, Male, Newborn, Ranibizumab, Recurrence, Retina, Retinopathy of Prematurity, Time Factors, Vascular Endothelial Growth Factor A",
author = "Ji, {M. H.} and Moshfeghi, {D. M.} and Callaway, {N. F.} and Z. Bodnar and Schachar, {I. H.} and Amorelli, {G. M.} and L. Orazi and F. Molle and Domenico Lepore",
year = "2019",
doi = "10.1016/j.oret.2019.06.017",
language = "English",
volume = "3",
pages = "913--915",
journal = "Ophthalmology Retina",
issn = "2468-6530",
publisher = "Elsevier Inc.",
number = "10",
}